Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2006 March; 7(1): E206–E214.
Published online 2006 March 24. doi:  10.1208/pt070129
PMCID: PMC2750736

Quantitation of drug content in a low dosage formulation by transmission near infrared spectroscopy


A transmission near infrared (NIR) spectroscopic method has been developed for the nondestructive determination of drug content in tablets with less than 1% weight of active ingredient per weight of formulation (m/m) drug content. Tablets were manufactured with drug concentrations of ~0.5%, 0.7%, and 1.0% (m/m) and ranging in drug content from 0.71 to 2.51 mg per tablet. Transmission NIR spectra were obtained for 110 tablets that constituted the training set for the calibration model developed with partial least squares regression. The reference method for the calibration model was a validated UV spectrophotometric method. Several data preprocessing methods were used to reduce the effect of scattering on the NIR spectra and base the calibration model on spectral changes related to the drug concentration changes. The final calibration model included the spectral range from 11 216 to 8662 cm−1 the standard normal variate (SNV), and first derivative spectral pretreatments. This model was used to predict an independent set of 48 tablets with a root mean standard error of prediction (RMSEP) of 0.14 mg, and a bias of only −0.05 mg per tablet. The study showed that transmission NIR spectroscopy is a viable alternative for nondestructive testing of low drug content tablets, available for the analysis of large numbers of tablets during process development and as a tool to detect drug agglomeration and evaluate process improvement efforts.

Full Text

The Full Text of this article is available as a PDF (249K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Rudnic EM, Schwartz JD, editors. Oral solid dosage forms. Baltimore, MD: Lippincott, Williams, & Wilkins; 2000. pp. 858–893.
2. Wu LS, Pang J, Chen JG, Hussain MA. Dry blending process scale-up for a very low dose drug candidate. AAPS Pharm Sci Tech. 2000;1:E–TN2. doi: 10.1208/pt0103_tn2. [PMC free article] [PubMed] [Cross Ref]
3. USP 28-NF19. US General Chapter 905, Uniformity of Dosage Forms. Rockville, MD: United States Pharmacopeial Convention; 2005.
4. Romañach RJ, Santos MA. Content uniformity testing with near infrared spectroscopy. Am Pharm Rev. 2003;6:62–67.
5. Blanco M, Coello J, Iturriaga H, Maspoch S, Pou N. Influence of the procedure used to prepare the calibration sample set on the performance of, near infrared spectroscopy in quantitative pharmaceutical analyses. Analyst. 2001;126:1129–1134. doi: 10.1039/b102090k. [PubMed] [Cross Ref]
6. Broad N, Jee R, Moffat C, Smith M. Application of transmission near-infrared spectroscopy to uniformity of content testing of intact steroid tablets. Analyst. 2001;126:2207–2211. doi: 10.1039/b106741a. [PubMed] [Cross Ref]
7. Ritchie GE, Roller RW, Ciurczak EW, Mark H, Tso C, MacDonald SA. Validation of a near-infrared transmission spectroscopic procedure, part B: application to alternate content uniformity and release assay methods, for pharmaceutical solid dosage forms. J Pharm Biomed Anal. 2002;29:159–171. doi: 10.1016/S0731-7085(02)00010-9. [PubMed] [Cross Ref]
8. Kemper MS, Magnuson EJ, Lowry SR, et al. Use of FT-NIR transmission spectroscopy for the quantitative analysis of an active ingredient in a translucent pharmaceutical topical gel formulation. AAPS Pharm Sci. 2002;3:E23–E23. doi: 10.1208/ps030323. [PMC free article] [PubMed] [Cross Ref]
9. Ramirez JL, Bellamy MK, Romañach RJ. A novel method for analyzing thick tablets by near infrared spectroscopy. AAPS Pharm Sci Tech. 2001;2:E11–E11. doi: 10.1208/pt020311. [PMC free article] [PubMed] [Cross Ref]
10. Laasonen M, Harmia-Pulkkinen T, Simard CR, Râsânen M, Vuorela H. Development and validation of a near-infrared method for the quantitation of caffeine in intact single tablets. Anal Chem. 2003;75:754–760. doi: 10.1021/ac026262w. [PubMed] [Cross Ref]
11. Scheiwe MW, Schilling D, Aebi P. Near infrared analysis of intact pharmaceutical diclofenac coated tablets in transmission. Pharm Ind. 1999;61:179–183.
12. Dyrby M, Engelsen SB, Nørgard L, Bruhn M, Lundsberg-Nielsen L. Chemometric quantitation of the active substance (containing C[equivalent]N) in a pharmaceutical tablet using near-infrared (NIR) transmittance and NIR FT-Raman spectra. Appl Spectrosc. 2002;56:579–585. doi: 10.1366/0003702021955358. [Cross Ref]
13. Jedvert I, Josefson M, Langkilde FW. Quantification of an active substance in a tablet by NIR and Raman spectroscopy. J Near Infrared Spectrosc. 1998;6:279–289.
14. Gottfries J, Depui H, Fransson M, et al. Vibrational spectrometry for the assessment of active substance in metoprolol tablets: a comparison between transmission and diffuse reflectance near infrared spectrometry. J Pharm Biomed Anal. 1996;14:1495–1503. doi: 10.1016/0731-7085(96)01800-6. [PubMed] [Cross Ref]
15. Beebe R, Pell RJ, Seasholtz MB. Multivariate Calibration and Prediction. New York, NY: John Wiley & Sons; 1998. pp. 280–280.
16. Blanco M, Coello J, Iturriaga H, Maspoch S, Pezuela C. Effect of data preprocessing methods in near-infrared diffuse reflectance spectroscopy for the determination of the active compound in a pharmaceutical component. Appl Spectrosc. 1997;51:240–246. doi: 10.1366/0003702971939947. [Cross Ref]
17. Olinger JM, Griffiths PR. Effects of sample dilution and particle size/morphology on diffuse reflection spectra of carbohydrate systems in the near- and mid-infrared. I. Single analytes. Appl Spectrosc. 1993;47:687–694. doi: 10.1366/0003702934066965. [Cross Ref]
18. Olinger JM, Griffiths PR. Effects of sample dilution and particle size/morphology on diffuse reflection spectra of carbohydrate systems in the near- and mid-infrared. II. Durum wheat. Appl Spectrosc. 1993;47:695–701. doi: 10.1366/0003702934067054. [Cross Ref]
19. Jouan-Rimbaud D, Walczak B, Massart DL, Last IR, Prebble KA. Comparison of multivariate methods based on latent vectors and methods based on wavelength selection, for the analysis of near-infrared spectroscopic data. Anal Chim Acta. 1995;304:285–295. doi: 10.1016/0003-2670(94)00590-I. [Cross Ref]
20. Duckworth J. Spectroscopic quantitative analysis. In: Workman J, Springsteen A, editors. Applied Spectroscopy: A Compact Reference for Practitioners. San Diego, CA: Academic Press; 1998. pp. 93–163.
21. Haaland DM, Thomas EV. Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information. Anal Chem. 1988;60:1193–1202. doi: 10.1021/ac00162a020. [Cross Ref]
22. Blanco M, Coello J, Eustaquio A, Iturriaga H, Maspoch S. Development and validation of methods for the determination of miokamycin in various pharmaceutical preparations by use of near infrared spectroscopy. Analyst. 1999;124:1089–1092. doi: 10.1039/a901774g. [PubMed] [Cross Ref]
23. Barnes RJ, Dhanoa MS, Lister SJ. Standard normal variate transformation and de-trending of near-infrared diffuse reflectance spectra. Appl Spectrosc. 1989;43:772–777. doi: 10.1366/0003702894202201. [Cross Ref]
24. Mark H, Ritchie GE, Roller RW, Ciurczak EW, Tso C, MacDonald SA. Validation of a near-infrared transmission spectroscopic procedure, part A: validation protocols. J Pharm Biomed Anal. 2002;28:251–260. doi: 10.1016/S0731-7085(01)00567-2. [PubMed] [Cross Ref]
25. ICH-Q2A, Guideline for Industry: Text on the validation of Analytical Procedures, 1995. Available at: Accessed: April 22, 2005.
26. ICH-Q2B, Validation of Analytical Procedures: Methodology, November 1996. Available at: Accessed: April 22, 2005.
27. Draper NR. Applied Regression Analysis. New York, NY: John Wiley & Sons; 1998.

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists